Heavily Pretreated RRMM: Patient Assessment &amp; Treatment Selection

107 Neratinib-Based Combination Treatments for Patients With HER2-Positive Breast Cancer Brain Metastases

Race, education, and arm pain were found to influence acupuncture expectancy in patients who are survivors of breast cancer.

Sarah Sammons;Rachel A. Freedman;Adam M. Brufsky;Ahmad Awada;Sara A. Hurvitz, MD;Nancy U. Lin, MD;Cristina Saura;Sheri Leung;Bethann S Hromatka

April 9th 2025

Chemo Effects May Outweigh Obesity-Related GI Alterations in Breast Cancer

Identifying biologic mechanisms driving symptoms may be necessary to develop therapies that reduce symptom burden for patients with breast cancer.

Roman Fabbricatore

Elevating the Quality of Cancer Care via Cross-Department Collaboration

Identifying biologic mechanisms driving symptoms may be necessary to develop therapies that reduce symptom burden for patients with breast cancer.

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD

April 7th 2025

FDA Grants IDE to Electrosurgical Device For Breast-Conservation Surgery

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Tim Cortese

FDA OKs Nivolumab/Ipilimumab in Unresectable/Metastatic HCC

The developer will conduct a US feasibility test to evaluate the safety and efficacy of the SIRA RFA Electrosurgical Device in patients who require breast-conservation surgery.

Ariana Pelosci;Tim Cortese

Social Detriments of Health Determine Acupuncture Expectancy in Breast Cancer

Results from the phase 3 CheckMate 9DW trial of nivolumab/ipilimumab vs lenvatinib or sorafenib led to the approval for patients with unresectable or metastatic HCC.

Related Content

Ariana Pelosci

107 Neratinib-Based Combination Treatments for Patients With HER2-Positive Breast Cancer Brain Metastases

Race, education, and arm pain were found to influence acupuncture expectancy in patients who are survivors of breast cancer.

Sarah Sammons;Rachel A. Freedman;Adam M. Brufsky;Ahmad Awada;Sara A. Hurvitz, MD;Nancy U. Lin, MD;Cristina Saura;Sheri Leung;Bethann S Hromatka

April 9th 2025

Chemo Effects May Outweigh Obesity-Related GI Alterations in Breast Cancer

Roman Fabbricatore

Elevating the Quality of Cancer Care via Cross-Department Collaboration

Identifying biologic mechanisms driving symptoms may be necessary to develop therapies that reduce symptom burden for patients with breast cancer.

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD

April 7th 2025

FDA Grants IDE to Electrosurgical Device For Breast-Conservation Surgery

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Tim Cortese

FDA OKs Nivolumab/Ipilimumab in Unresectable/Metastatic HCC

The developer will conduct a US feasibility test to evaluate the safety and efficacy of the SIRA RFA Electrosurgical Device in patients who require breast-conservation surgery.

Ariana Pelosci;Tim Cortese